Optimizing communication in patients with IPF

Published Date: 08 Mar 2023

Dr. Fernando Martinez and respiratory nurse Nadine Chahine discuss effective communication strategies for patients and families affected by idiopathic pulmonary fibrosis.

Read Full News

Latest News

Time to Rethink Early Morning In-Hospital Blood Draws?

Delaying in-hospital blood draws by just 2 hours helped sleep quality and quantity, researchers find. Now, some hospitals are considering a change to traditional timing.

Liver Enzyme Guides Prognosis in CKD Patients on Dialysis

Among patients with CKD, serum total ALP and its liver, bone, and intestinal fractions increase with disease severity, and liver ALP is associated with mortality in those undergoing haemodialysis.

COVID Shots in Pregnancy Protect Infants’ First 6 Months

The research adds important evidence for clinicians counseling pregnant patients.

Medical Accuracy of 'The Pitt'

The cast and creators of HBO Max's 'The Pitt' explain how they get the medicine right, and why it matters.

‘I HATE YOU’ and Other Things People Say to Their Doctors

Patient rudeness, in-person or on the portal, is more common than ever, and data now show it’s taking a toll on quality care.

Barzolvolimab Shows Persistent Benefits for CSU

Patients maintain their improvements off treatment, even after clearance of barzolvolimab, investigators report.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Latest News

Delaying in-hospital blood draws by just 2 hours helped sleep quality and quantity, researchers find. Now, some hospitals are considering a change to traditional timing.

Among patients with CKD, serum total ALP and its liver, bone, and intestinal fractions increase with disease severity, and liver ALP is associated with mortality in those undergoing haemodialysis.

The research adds important evidence for clinicians counseling pregnant patients.

The cast and creators of HBO Max's 'The Pitt' explain how they get the medicine right, and why it matters.

Patient rudeness, in-person or on the portal, is more common than ever, and data now show it’s taking a toll on quality care.

Patients maintain their improvements off treatment, even after clearance of barzolvolimab, investigators report.

News All Time

IgAn Diagnostic and Therapeutic Strategies

Explore how updated KDIGO IgAN guidelines, earlier biopsy driven risk stratification, and new targeted therapies (budesonide, sparsentan, complement/APRIL inhibitors) are reshaping long term outcomes.

Change Healthcare Breach Still Affecting Docs, Hospitals

Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024.

Peanut Introduction Kits Encourage Earlier Peanut Feeding

Peanut kits given in pediatric clinics were linked to a threefold increase in caregivers introducing the legume 2 months later.

Which Allergens Trigger Contact Dermatitis in HCPs?

Occupational contact dermatitis affects North American healthcare workers and is commonly linked to glove rubber accelerators, surfactants, and preservatives, a retrospective study finds.

Panel Endorses Early Introduction of Food Allergens

A panel convened by the FDA also called for more attention to skin sensitization.

Multitargeted Therapy in Kids With IMIDs: Is It Effective?

In kids with immune-mediated inflammatory diseases, multitargeted therapy may benefit some, with over half achieving remission, although more than 1 in 4 require hospitalization for infections.

Being Honest About Uncertainty Fosters Trust

Acknowledging uncertainty about the limits of scientific research can foster trust in public health messaging and improve overall science literacy.

Depemokimab Shows Promise in Type 2 Asthma With Nasal Polyps

An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic rhinosinusitis with nasal polyps.

How to Build Trust When Patients Believe Misinformation

Successful communication is built on trust.

New ECDC Panel to Develop Adult RSV Vaccination Guidance

The ECDC, the infectious diseases watchdog, has asked for scientists to join its new panel on RSV as Europe begins to vaccinate its most vulnerable adults.

South Carolina Reports Three New Measles Cases, Outbreak Total Rises to 996

South Carolina health officials reported three new measles cases on ⁠Friday, pushing the total number of infections linked to the outbreak ⁠to 996, the state health...

Survey Reveals Gaps in Pediatric EMS Readiness in the US

Out-of-hospital readiness in pediatric emergency medical service agencies in the US is modest; gaps remain in family-centered care, quality improvement, and coordination of care.

Can Beta-Lactam Loading Help Tackle Resistant Klebsiella?

Loading dose regimen of beta-lactam may speed early bacterial clearance and improve clinical stability in non-ICU patients with resistant K pneumoniae bloodstream infections, a real-world study shows.

Enhanced-Delivery Chamber May Reduce Wheezing in Kids

A valved holding chamber with high drug delivery performance may reduce wheezing severity and hospitalizations more effectively than a device with lower delivery in young children, a trial shows.

Roflumilast Effective, Safe for AD in Children Over 56 weeks

Roflumilast cream 0.05% provides durable efficacy and is well-tolerated for up to 56 weeks in children aged 2-5 years with mild-to-moderate atopic dermatitis, a study finds.

Omalizumab Enables Safe Allergenic Food Introduction in Kids

Omalizumab treatment allows most children with immunoglobulin E-mediated food allergy to complete oral food challenges and undergo dietary introduction.